BioAge Labs, Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -1,196.6% | -827.9% | -781.1% | -917.8% | -867.5% | -785.8% | -846.0% | |
| – | – | – | – | – | – | 2.5% | 2.4% | 2.4% | 2.2% | 2.3% | 2.9% | 2.4% | |
| – | – | – | – | – | – | 203.2% | 133.9% | 135.9% | 88.4% | 153.5% | 174.2% | 135.6% | |
| – | – | – | – | – | – | -519.1% | -74.1% | 59.7% | -121.4% | -216.2% | 115.0% | -54.9% | |
| – | – | – | – | – | – | 29.4% | 6.6% | 1.1% | 3.6% | 0.9% | 13.4% | 4.7% | |
| – | – | – | – | – | – | -5,374.8% | -648.5% | 625.2% | -468.7% | -1,686.6% | -6,712.1% | -2,055.6% | |
| – | – | – | – | – | – | -103.4% | -62.2% | -73.0% | -48.7% | -54.1% | -47.3% | -54.7% | |
| – | – | – | – | – | – | -103.4% | -62.2% | -75.2% | 520.2% | 4,463.0% | 651.4% | 1,488.7% | |
| – | – | – | – | – | – | -6,675.6% | -1,540.5% | -231.6% | -867.0% | 1,908.0% | -6,846.7% | -1,413.5% | |
| – | – | – | – | – | – | -1,226.0% | -834.5% | -782.2% | -921.5% | -868.4% | -799.2% | -850.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.